The rapid development of COVID-19 vaccines has accentuated the need for investment in foundational research.
Even in its dubious goal of increasing taxes, Obamacare fell short.
The Trump administration wants to force banks to lend to oil and gun companies.
The president-elect should pay close attention to mortality costs of binding federal regulations.
The botched rollout of COVID-19 vaccines highlights yet again the superiority of markets to central planning.